Patents by Inventor Mohammed Eslam

Mohammed Eslam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210395751
    Abstract: The present disclosure relates to compositions and methods for treating viral infections and in particular for treating hepatitis B and hepatitis D viral infections. A method of treating a hepatitis B virus infection in a subject the method comprising administering to the subject an inhibitor wherein the inhibitor inhibits or suppresses a regulator of liver lipid metabolism in the subject.
    Type: Application
    Filed: October 24, 2019
    Publication date: December 23, 2021
    Inventors: Mark William Douglas, Mohammed Eslam, George Jacob, Anis Khan
  • Patent number: 10939868
    Abstract: This invention relates to molecular diagnostics and, more specifically DNA-based tests for the prognosis and/or monitoring of fibrotic disease progression in humans, and processes for stratifying patients based on their likely rates of fibrotic disease progression. The invention also relates to the field of therapy for fibrotic disease, based on such prognoses, monitoring and stratification results, such as in monitoring and/or stratifying and/or treating patients having a higher likelihood of rapid fibrotic disease progression.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: March 9, 2021
    Assignees: WESTERN SYDNEY LOCAL HEALTH DISTRICT, THE UNIVERSITY OF SYDNEY
    Inventors: David Booth, Jacob George, Mohammed Eslam, Golo Ahlenstiel, Kate O'Connor